We are open but due to high demand and courier delays, delivery times are expected to be longer.
0

Call Boomerang Books 1300 36 33 32

Description - Innovative Drug Synthesis by Jie Jack Li

This book covers all aspects of the medicinal chemistry of the latest drugs, and the cutting-edge science associated with them. Following the editors' 3 successful drug synthesis books, this provides expert analysis of the pros and cons of different synthetic routes and demystifies the process of modern drug discovery for practitioners and researchers.

  • Summarizes for each drug: respective disease area, important properties and SAR (structure-activity relationship), and chemical synthesis routes / options
  • Includes case studies in each chapter
  • Illustrates how chemistry, biology, pharmacokinetics, and a host of disciplines come together to produce successful medicines
  • Explains the advantages of process synthesis versus the synthetic route for drug discovery

Buy Innovative Drug Synthesis by Jie Jack Li from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9781118820056
ISBN-10: 1118820053
Format: Hardback
(260mm x 183mm x 24mm)
Pages: 360
Imprint: John Wiley & Sons Inc
Publisher: John Wiley & Sons Inc
Publish Date: 26-Jan-2016
Country of Publication: United States

Book Reviews - Innovative Drug Synthesis by Jie Jack Li

» Have you read this book? We'd like to know what you think about it - write a review about Innovative Drug Synthesis book by Jie Jack Li and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)


Author Biography - Jie Jack Li

Jie Jack Li is an Associate Professor of chemistry at the University of San Francisco. Previously, he was a chemist at Bristol-Myers Squibb Company. He has authored or edited several books published by Wiley, including Drug Discovery: Practices, Processes, and Perspectives, Heterocyclic Chemistry in Drug Discovery, Name Reactions in Heterocyclic Chemistry, Name Reactions for Functional Group Transformations, Contemporary Drug Synthesis, The Art of Drug Synthesis, and Modern Drug Synthesis. Douglas Johnson is an Associate Research Fellow and head of Chemical Biology in the Neuroscience Medicinal Chemistry group at Pfizer Worldwide Research and Development. He is a co-author on more than 70 publications and patents and is a co-author of the book Contemporary Drug Synthesis and is an editor of The Art of Drug Synthesis, and Modern Drug Synthesis (all published by Wiley).

A Preview for this title is currently not available.